Form 8-K - Current report:
SEC Accession No. 0001193125-25-137135
Filing Date
2025-06-06
Accepted
2025-06-06 16:42:34
Documents
16
Period of Report
2025-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d864561d8k.htm   iXBRL 8-K 43936
2 EX-4.1 d864561dex41.htm EX-4.1 80261
3 EX-10.1 d864561dex101.htm EX-10.1 164197
4 EX-99.1 d864561dex991.htm EX-99.1 22569
8 GRAPHIC g864561g0606232547831.jpg GRAPHIC 2038
  Complete submission text file 0001193125-25-137135.txt   514218

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hura-20250602.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20250602_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20250602_pre.xml EX-101.PRE 11265
19 EXTRACTED XBRL INSTANCE DOCUMENT d864561d8k_htm.xml XML 3718
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 251031350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)